Objective response rate and progression-free survival as surrogates for overall survival treatment effect: A meta-analysis across diverse tumour groups and contemporary therapies

医学 代理终结点 内科学 随机对照试验 肿瘤科 无进展生存期 恶性肿瘤 总体生存率 黑色素瘤 癌症研究
作者
Adel Shahnam,Nadia Hitchen,Udit Nindra,Sathya Manoharan,Jayesh Desai,Ben Tran,Benjamin Solomon,Stephen J. Luen,Rina Hui,Ashley M. Hopkins,Michael J. Sorich
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:198: 113503-113503 被引量:6
标识
DOI:10.1016/j.ejca.2023.113503
摘要

Background Overall survival (OS) results from randomized control trials (RCT) provide the strongest evidence for efficacy of anti-cancer treatments but can take a considerable amount of time to mature. Progression free survival (PFS) and objective response rate (ORR) are used as an early surrogate of OS treatment effect however their validity remains unclear. Our study aims to comprehensively evaluate ORR and PFS as surrogates for OS treatment effect across tumor groups and treatment types. Material and Methods Phase 3 RCTs in solid malignancies that reported OS/PFS and ORR published between 1st of January 2010 and 30th of June 2022 were evaluated. The relationship of surrogate endpoints and OS treatment effect was assessed via weighted linear regression. The coefficient of determination (R2) quantified the fit of the regression model. Results 675 phase 3 RCT comprising of 350 112 patients were analysed. ORR (R2 of 0.10) and PFS (R2 of 0.38) were poor surrogate markers of OS treatment effect. The strength of surrogacy differed within treatment and tumour groups. PFS had the highest R2 for chemotherapy (0.56) and lowest for targeted therapy (0.40). PFS had the highest level of surrogacy for melanoma (R2 = 0.72) and pancreatic cancer (R2 = 0.70) compared to other tumour groups. Importantly ORR and PFS were also poorly correlated to each other (R2 = 0.33). Conclusions ORR and PFS were poor trial-level surrogate markers of OS. The surrogacy performance of ORR and PFS differed by treatment and malignancy sub-type.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hp发布了新的文献求助30
2秒前
yyauthor完成签到,获得积分10
2秒前
Quinna发布了新的文献求助10
4秒前
5秒前
8秒前
量子星尘发布了新的文献求助10
9秒前
cathy-w完成签到,获得积分0
10秒前
Sunnyside发布了新的文献求助10
10秒前
wenxiansci完成签到,获得积分0
11秒前
11秒前
13秒前
嗯嗯完成签到,获得积分10
14秒前
Zsir完成签到,获得积分10
14秒前
完美世界应助酷酷的友灵采纳,获得10
15秒前
英姑应助十九岁的时差采纳,获得10
18秒前
19秒前
ableyy完成签到,获得积分10
19秒前
19秒前
hhhblabla应助等待的花生采纳,获得10
20秒前
寒冷的小chao关注了科研通微信公众号
20秒前
22秒前
李李完成签到 ,获得积分10
22秒前
22秒前
lucy_zi发布了新的文献求助10
24秒前
闪闪w完成签到,获得积分10
25秒前
欣喜沛芹发布了新的文献求助10
26秒前
潇湘雪月发布了新的文献求助10
27秒前
27秒前
完美世界应助Bressanone采纳,获得10
28秒前
31秒前
徐哈哈发布了新的文献求助10
33秒前
35秒前
36秒前
37秒前
研友_VZG7GZ应助欣喜沛芹采纳,获得10
38秒前
感动黄豆完成签到,获得积分20
39秒前
40秒前
40秒前
42秒前
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989242
求助须知:如何正确求助?哪些是违规求助? 3531393
关于积分的说明 11253753
捐赠科研通 3270010
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136